Home › Funds › BlackRock Inc › CPRX
BlackRock Inc position in CPRX
CATALYST PHARMACEUTICALS INC
Latest position (Q2 2026)19.16M sh
Reported value held$602.16M
Portfolio Weight0.01%
First reportedQ3 2024
Last changeAdd
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q3 2024 | 19.02M | $378.07M | New |
| Q4 2024 | 19.43M | $405.40M | Add |
| Q1 2025 | 18.80M | $456.01M | Reduce |
| Q2 2025 | 18.90M | $410.14M | Add |
| Q3 2025 | 18.22M | $358.86M | Reduce |
| Q4 2025 | 18.63M | $434.75M | Add |
| Q1 2026 | 18.77M | $464.86M | Add |
| Q2 2026 | 19.16M | $602.16M | Add |
Dots on the line are colored by change type; missing quarters mean no position was reported.
Other funds holding CPRX
- Vanguard Group 8.43M sh · $196.81M · Q4 2025
- JPMorgan Chase & Co 3.17M sh · $99.89M · Q2 2026
- Geode Capital Management 3.15M sh · $99.03M · Q2 2026
- Morgan Stanley 2.76M sh · $86.76M · Q2 2026
- Renaissance Technologies 2.14M sh · $67.14M · Q2 2026
- Janus Henderson Group 2.00M sh · $49.52M · Q1 2026
- UBS Group AG 1.45M sh · $45.69M · Q2 2026
- Northern Trust Corp 1.33M sh · $41.82M · Q2 2026
- Bank of America Corp 1.31M sh · $41.22M · Q2 2026
- Goldman Sachs Group 1.19M sh · $37.53M · Q2 2026
- Charles Schwab Investment Management 1.16M sh · $36.44M · Q2 2026